A carregar...

Docetaxel and Mitoxantrone Prior to Radical Prostatectomy in Men with High Risk Prostate Cancer: Ten-Year Follow Up and Immune Correlates

OBJECTIVES. To report the clinical outcomes a cohort of men with high-risk prostate cancer treated with neoadjuvant docetaxel and mitoxantrone ten years after treatment. To identify pretreatment clinical parameters that maybe predictors of recurrence, and to describe tumor infiltrating leukocytes pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Anticancer Drugs
Main Authors: Bergstrom, Colin P., Ruffell, Brian, Ho, Christine M.T., Higano, Celestia S., Ellis, William J., Garzotto, Mark, Beer, Tomasz M., Graff, Julie N.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7370800/
https://ncbi.nlm.nih.gov/pubmed/27669423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000438
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!